Boston Scientific
Who Should Receive Cerebral Embolic Protection
This is video #7 of a 7 part series on Cerebral Embolic Protection for Ischemic Stroke.
In this recorded interactive Q&A session from the SENTINEL Therapy Awareness webinar, Drs. Hemal Gada and David Rose answer questions on device deployment, patient selection, and the PROTECTED TAVR clinical trial.
Comments 0
Login to view comments.
Click here to Login
